AT270864B - Verfahren zur Herstellung von für immunochemische Bestimmungen von Antigenen geeigneten Erythrocyten - Google Patents

Verfahren zur Herstellung von für immunochemische Bestimmungen von Antigenen geeigneten Erythrocyten

Info

Publication number
AT270864B
AT270864B AT284467A AT284467A AT270864B AT 270864 B AT270864 B AT 270864B AT 284467 A AT284467 A AT 284467A AT 284467 A AT284467 A AT 284467A AT 270864 B AT270864 B AT 270864B
Authority
AT
Austria
Prior art keywords
erythrocytes
antigens
preparation
immunochemical
determinations
Prior art date
Application number
AT284467A
Other languages
German (de)
English (en)
Inventor
David Dr Dingwall
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of AT270864B publication Critical patent/AT270864B/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555Red blood cell
    • G01N33/556Fixed or stabilised red blood cell
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • Y10S436/818Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT284467A 1966-03-24 1967-03-23 Verfahren zur Herstellung von für immunochemische Bestimmungen von Antigenen geeigneten Erythrocyten AT270864B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603909A NL6603909A (es) 1966-03-24 1966-03-24

Publications (1)

Publication Number Publication Date
AT270864B true AT270864B (de) 1969-05-12

Family

ID=19796083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT284467A AT270864B (de) 1966-03-24 1967-03-23 Verfahren zur Herstellung von für immunochemische Bestimmungen von Antigenen geeigneten Erythrocyten

Country Status (12)

Country Link
US (1) US3548051A (es)
AT (1) AT270864B (es)
BE (1) BE696050A (es)
CH (1) CH508390A (es)
DE (1) DE1617672A1 (es)
DK (1) DK126452B (es)
ES (1) ES338201A1 (es)
GB (1) GB1179131A (es)
GR (1) GR36578B (es)
IL (1) IL27578A (es)
NL (2) NL6603909A (es)
SE (1) SE335592B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
DE2310964A1 (de) * 1973-03-02 1974-09-05 Schering Ag Antigen- bzw. antigen-proteinkonjugatbeschichtete erythrocytenpraeparation
US4136161A (en) * 1976-03-16 1979-01-23 Ortho Diagnostics, Inc. Stabilized erythrocytes and methods therefor
JPS55162059A (en) * 1979-06-05 1980-12-17 Mochida Pharmaceut Co Ltd Measuring method for antigen, antibody or their complex and measurement reagent kit
US4282002A (en) * 1979-09-06 1981-08-04 Akzona Incorporated Sensitized sheep stroma immunoassay for rheumatoid factor
FR2476320B1 (fr) * 1980-02-15 1985-10-25 Guffroy Rene Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif
US4609630A (en) * 1983-03-23 1986-09-02 Yanovsky Jorge F Method for improving the specificity of immunoassays
IL90188A0 (en) * 1988-05-18 1989-12-15 Cryopharm Corp Process and medium for the lyophilization of erythrocytes
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
EP0356258A3 (en) * 1988-08-26 1990-06-06 Cryopharm Corporation Processes for the lyophilization of red blood cells, together with media for lyophilization
WO2005072523A2 (en) * 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Biological material and methods and solutions for preservation thereof
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
JP2022525742A (ja) 2019-03-14 2022-05-19 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー 凍結乾燥用ローディングトレイ組立体及びシステム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096250A (en) * 1959-11-30 1963-07-02 Indiana University Foundation Novel particulate antigens and process
US3236732A (en) * 1962-01-22 1966-02-22 Edward R Arquilla Pregnancy test method and immunological indicator therefor

Also Published As

Publication number Publication date
ES338201A1 (es) 1968-04-01
DK126452B (da) 1973-07-16
GR36578B (el) 1969-02-21
DE1617672A1 (de) 1971-04-01
NL6603909A (es) 1967-09-25
SE335592B (es) 1971-06-01
CH508390A (de) 1971-06-15
NL126572C (es)
US3548051A (en) 1970-12-15
GB1179131A (en) 1970-01-28
IL27578A (en) 1971-04-28
BE696050A (es) 1967-09-25

Similar Documents

Publication Publication Date Title
CH524577A (de) Verfahren zur Herstellung von Aminoguanidinen
AT270864B (de) Verfahren zur Herstellung von für immunochemische Bestimmungen von Antigenen geeigneten Erythrocyten
CH487916A (de) Verfahren zur Herstellung von 2-Cycloalkylamino-oxazolinen
CH484108A (de) Verfahren zur Herstellung von Pyrrylaminoäthanolen
CH490294A (de) Verfahren zur Herstellung von 3-Methylpentenen
CH485731A (de) Verfahren zur Herstellung von 3-Amino-4-carboxamidopyrazol
CH484016A (de) Verfahren zur Herstellung von Hydrindacenen
CH479626A (de) Verfahren zur Herstellung von Organooxysilanen
CH491064A (de) Verfahren zur Herstellung von Diaceton-L-sorbose
CH496650A (de) Verfahren zur Herstellung von 4-Fluoro-3-nitroanilin
CH491857A (de) Verfahren zur Herstellung von Phenoxyaminoalkanolen
CH484155A (de) Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
CH487177A (de) Verfahren zur Herstellung von Thiaimidazolidinen
CH484104A (de) Verfahren zur Herstellung von Bis-thiosemicarbazonen
CH490358A (de) Verfahren zur Herstellung von 17a-Äthinyl-17B-hydroxysteroiden
CH472381A (de) Verfahren zur Herstellung von Monohalogeno- azeto-azetamiden
AT288349B (de) Verfahren zur Herstellung von Monoalkylbenzolen
AT277957B (de) Verfahren zur Herstellung von Alkenonen
CH495333A (de) Verfahren zur Herstellung von Trihalogenäthylglycinaten
CH490377A (de) Verfahren zur Herstellung von Aminohydrinen
CH487860A (de) Verfahren zur Herstellung von Arylsulfonylsemicarbaziden
CH477470A (de) Verfahren zur Herstellung von Ribofuranosiden
AT273165B (de) Verfahren zur Herstellung von Diphenylsilandiolen
AT276763B (de) Verfahren zur Herstellung von Polyacyloxamidrazonen
AT274780B (de) Verfahren zur Herstellung von 1-Acylaminoadamantanen